Targeting ALK, ROS1, and BRAF kinases. | Colorado PROFILES

Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)

Menu

History

Contemporary use of ad

Targeting ALK, ROS1, a

See All (2) pages

Contact Us
If you have any questions or feedback please contact us.

Targeting ALK, ROS1, and BRAF kinases.

Doebele RC, Camidge DR. Targeting ALK, ROS1, and BRAF kinases. J Thorac Oncol. 2012 Dec; 7(16 Suppl 5):S375-6.

View in: PubMed

subject areas

authors with profiles

David Ross Camidge

Copyright © 2024 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)